APA (7th ed.) Citation

Díaz‐Jordán, B. L., Cebanu, T., Barcenilla, S. G., & Álvarez‐Román, M. T. (2023). Real‐world experience of rIX‐FP prophylaxis at dosing intervals of up to 14 days in a pediatric patient with hemophilia B during the COVID‐19 pandemic. Clinical Case Reports, 11(12), . https://doi.org/10.1002/ccr3.8180

Chicago Style (17th ed.) Citation

Díaz‐Jordán, Bolívar Luis, Tamara Cebanu, Sara García Barcenilla, and Maria Teresa Álvarez‐Román. "Real‐world Experience of RIX‐FP Prophylaxis at Dosing Intervals of Up to 14 Days in a Pediatric Patient with Hemophilia B During the COVID‐19 Pandemic." Clinical Case Reports 11, no. 12 (2023). https://doi.org/10.1002/ccr3.8180.

MLA (9th ed.) Citation

Díaz‐Jordán, Bolívar Luis, et al. "Real‐world Experience of RIX‐FP Prophylaxis at Dosing Intervals of Up to 14 Days in a Pediatric Patient with Hemophilia B During the COVID‐19 Pandemic." Clinical Case Reports, vol. 11, no. 12, 2023, https://doi.org/10.1002/ccr3.8180.